
PwC's Next in Health
Co -hosted by Glenn Hunzinger, US Health Industries leader, and Jennifer Colapietro, Consulting Commercial Leader, the Next in Health podcast series offers insights on the most important issues facing pharma, medtech and healthcare. PwC business leaders discuss the latest trends and their impact on health industries, whether it’s policy, AI, innovation, care delivery, business model reinvention or bold moves for the future. If it’s happening in health industries, we’re talking about it.
PwC's Next in Health
Key strategies for global pharma companies to reduce risk and drive growth in the China market
Tune in to hear PwC specialists discuss their recently published article: How a local-first strategy in China can help global pharma and life sciences players reduce risk and drive growth. Topics include:
- Sharing key strategies for pharma companies contemplating localization in China, offering valuable insights on maximizing business growth while mitigating risks in the Chinese market
- Three approaches organizations can consider to competing at a local level in China
- Impacts to different functions across the value chain such as R&D, supply chain, and IT
Speakers:
Nalneesh Gaur, Partner, Pharmaceutical and Life Sciences Cybersecurity, PwC
Ben Rhee, Principal, Pharmaceutical and Life Sciences Enterprise Strategy and Value, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.